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Abstract
Background: Chronic Myelomonocytic Leukemia (CMML) is a heterogeneous disease that is not only hard to diagnose and
classify, but is also highly resistant to treatment. Available forms of therapy for this disease have not shown significant
effects and patients rapidly develop resistance early on in therapy. These factors lead to the very poor prognosis observed
with CMML patients, with median survival duration between 12 and 24 months after diagnosis. This study is therefore
centered around evaluating the selective efficacy of a natural extract from dandelion roots, in inducing programmed cell
death in aggressive and resistant CMML cell lines.
Methodology/Principal Findings: To confirm the induction of programmed cell death in three human CMML cell lines,
nuclear condensation and externalization of the phosphatidylserine, two main characteristics of apoptosis, were detected
using Hoechst staining and annexin-V binding assay. The induction of another mode of cell death, autophagy, was
determined using a monodansylcadaverine (MDC) stain, to detect the formation of autophagy vacuoles. The results from
this study indicate that Dandelion Root Extract (DRE) is able to efficiently and selectively induce apoptosis and autophagy in
these cell lines in a dose and time dependent manner, with no significant toxicity on non-cancerous peripheral blood
mononuclear cells. More importantly, we observed early activation of initiator caspase-8, which led to mitochondrial
destabilization and the induction of autophagy, suggesting that DRE acts through the extrinsic pathway of apoptosis. The
inability of DRE to induce apoptosis in dominant-negative FADD cells, confirms the mechanism of action of DRE in in vitro
models of CMML.
Conclusion: The results from this study indicate that natural products, in particular Dandelion Root Extract, have great
potential, as non-toxic and effective alternatives to conventional modes of chemotherapy available today.
Citation: Ovadje P, Hamm C, Pandey S (2012) Efficient Induction of Extrinsic Cell Death by Dandelion Root Extract in Human Chronic Myelomonocytic Leukemia
(CMML) Cells. PLoS ONE 7(2): e30604. doi:10.1371/journal.pone.0030604
Editor: Keshav K. Singh, University of Alabama at Birmingham, United States of America
Received October 20, 2011; Accepted December 25, 2011; Published February 17, 2012
Copyright:  2012 Ovadje et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Seeds4Hope: Grant #: 810257, Knights of columbus: Grant #: 850285, and a Kevin Couvillion Memorial grant: 810340. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: spandey@uwindsor.ca
Introduction
The risk of developing cancer increases with age; nonetheless it can
affect all ages [1]. Chronic Myelomonocytic Leukemia (CMML) is a
highlyaggressiveandresistantformofleukemiawithahighlyvariable
natural course of progression. The difficulty in diagnosing this disease
contributes to its aggressive and resistant nature. In recent years, the
World Health Organization (WHO) has classified this disease as both
a myeloproliferative disease (MPD) and a myelodysplastic syndrome
(MDS) [2,3]. This classification system has improved diagnosis of
CMML, although it can still prove difficult. Even with advances in
chemotherapy research, the prognosis for CMML still remains very
poor with median survival of 12 to 24 months [3]. The available
forms of treatment come with very severe side effects, with patients
developing resistance early on during treatment. The only effective
form of treatment that has shown significant success in CMML
patients is Hematopoietic Stem Cell Transplantation, although very
few studies have been done with CMML MDS/MPD [4]. It is
therefore of utmost importance to develop more modes of treatment
that are not only safe, but also effective in targeting CMML cells
specifically.
Natural products have been used for centuries as a source of
nutrition, nourishment and for various forms of therapy for a wide
range of diseases. Recent reports indicate that over the past sixty
years, more than 60% of the approved anti-cancer drugs have been
either natural or derived from natural products [5]. Taraxacum
Officinale, commonly known as Dandelion, are perennial weeds of
the Asteracaea family, thought to have originated in central Asia
but now known to grow almost anywhere in the world today.
Traditional medicine, especially Traditional Chinese Medicine, has
encouraged the use of dandelion extracts for the treatment of
various diseases, ranging from diarrhoea and digestive diseases to
more serious ailments like hepatitis and anorexia [6,7]. There have
beenvery fewscientificstudies to ascertainmany claimsof theuse of
dandelion extracts in the treatment of diseases, but recently, studies
indicate this plant has anti-inflammatory, antioxidant and anti-
carcinogenic activities [6]. Our group is studying the anticancer
effects of dandelion root extract (DRE), by evaluating its ability to
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CMML cells. Previous work done by our group showed that DRE
effectively induced apoptosis in human T cell leukemia (Jurkat) and
melanoma cells, by rapidly activating the death-receptor mediated
extrinsic pathway of apoptosis [8,9]. In this study, the efficacy of
DRE in more aggressive leukemia cell lines was assessed to
determine its selectivity and efficacy in inducing apoptosis/
autophagy in CMML cells. Results indicate that DRE effectively
induces apoptosis and autophagy in a dose and time dependent
manner. The rapidactivation ofcaspase-8,throughtheactivation of
the extrinsic pathway of apoptosis, was observed in these cells,
comparable to levels found in Jurkat cells. Non-cancerous
peripheral blood mononuclear cells (ncPBMCs), treated with
dandelion root extract in parallel, were not susceptible to apoptosis,
demonstrating the selectivity of dandelion root extract in cell
culture. Results from this study indicate that dandelion root extract
could potentially represent a novel non-toxic alternative to
conventional cancer therapy available today.
Results
DRE effectively induces apoptosis in Chronic
Myelomonocytic Leukemia cells
To assess the effect of Dandelion Root Extract in aggressive and
resistant human chronic myelomonocytic leukemia cells, MV-4-
11, HL-60 and U-937 cells were treated with increasing
concentrations of DRE for increasing time points. These cells
were analyzed for the induction of apoptosis, using Hoechst and
Annexin-V binding assay. Apoptosis was characterized by
condensation of the nuclear chromatin and the externalization
of the phosphatidylserine to the outer leaflet of the cell’s
membrane [10]. Results indicate that DRE efficiently induced
apoptosis in highly aggressive and resistant leukemia cells in a
dose- and time-dependent manner (Fig. 1), as an increase in the
percentage of apoptotic cells corresponded to an increase in
the dose and time of exposure. Another characteristic feature of
apoptosis is nuclear DNA fragmentation, that can be observed
after cleavage of caspase-3 [11]. To further confirm the induction
of apoptosis, TUNEL assay was used to quantify DNA
fragmentation in these cells after exposure to DRE. Etoposide, a
known chemotherapy that targets topoisomerase II [10], was used
as a positive control for DNA fragmentation. Results indicate that
DRE activated the apoptotic pathways leading to late DNA
fragmentation, compared to etoposide, which caused DNA
fragmentation that led to the induction of apoptosis (Fig. 2). For
a more quantitative assessment of the effect of DRE on CMML
cells, these cells were treated with DRE and analyzed for the effect
of this extract on the viability of these cells in a time-dependent
manner. Results observed indicate that treatment with DRE led to
a decrease in the viability of MV-4-11 cells as a function of
Figure 1. DRE induces apoptosis in CMML cells in a dose dependent manner. MV-4-11, HL-60 and U-937 cells were treated with increasing
doses of DRE and analyzed for the induction of apoptosis. (a) Hoechst and Annexin-V staining of DRE-treated CMML cells 48 hours after treatment.
Magnification 4006. (b) Manual quantification of three individual experiments of DRE-treated cells, 48 hours after. 6 pictures were obtained for every
sample and live versus dead cells were counted to ascertain the percent apoptotic cell count for every sample. Experiment was performed three
times and the mean and standard deviation of the three experiments were obtained.
doi:10.1371/journal.pone.0030604.g001
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This extract led to a 60% decrease in the viability of treated cells
compared to the control, untreated cells, indicating that DRE
could potentially affect the metabolic activity of CMML cells,
ultimately leading to cell death, observed in Fig. 1a. Since we
observed an approximate decrease in viability of 60% of MV-4-11
cells 96 hours after treatment with DRE, the next step was to
determine if DRE has any effect on the other 40% of cells that did
not show any apoptotic morphology 96 hours after treatment.
MV-4-11 cells were treated with DRE and after 48 hours the cells
were removed, from media containing DRE, washed and equal
numbers of cells were re-plated (for control and treated cells) in
fresh media without the extract. These cells were then analyzed for
their ability to revive growth after previous exposure to DRE.
Although MV-4-11 cells continued to grow in the absence of
DRE, it was observed that cells previously treated with DRE had
reduced ability to revive growth and therefore grew at a slower
pace than the cells not treated with DRE for 48 hours. More
importantly, it was observed that treatment with a second dose of
DRE, after 48 hours, could induce apoptosis successfully in all the
Figure 2. DRE induces late stage DNA damage in MV-4-11 cells.
MV-4-11 cells were treated with 1.0 mg/ml DRE and 10 mM VP-16 at the
indicated time points to determine if DNA damage was the cause or
effect of apoptosis observed in CMML cells. Following treatment, cells
were fixed and immunostained with anti-BrdU antibody to observe
DNA damage. Increase in TUNEL positive staining corresponds with an
increase in levels of DNA damage following treatment. More positively
stained cells are observed in the final stages of apoptosis caused by
DRE, compared to the DNA targeting drug, VP-16. magnification: 2006.
doi:10.1371/journal.pone.0030604.g002
Figure 3. DRE reduces the viability of MV-4-11 cells in a time dependent manner. (a). MV-4-11 cells were plated in 96-well clear bottom
plates and treated with DRE at indicated time points and analyzed for the ability of DRE to reduce the viability of these cells, measured by a decrease
in metabolic activity. Following treatment, the WST-1 reagent was added to each well, the absorbance readings were taken at 450 nm, and expressed
at a percentage of the control. The absorbance readings were analyzed using GraphPad Prism version5.0 and values are expressed as mean 6 SD
from quadruplicates of 3 independent experiments. (b). Following treatment with DRE for 48 hours, MV-4-11 cells were removed from media
containing DRE and equal number of cells were replated in fresh media, with no extract and allowed to grow for 96 hours, observing growth every
24 hours by trypan blue exclusion assay (left). As a single dose of DRE slowed down growth of MV-4-11 cells but did not completely halt this growth,
MV-4-11 cells were treated with DRE for 48 hours, then treated with a second dose of DRE after the first 48 hours. Subsequent to the second
treatment, cells were observed for growth ability (right), using trypan blue exclusion assay.
doi:10.1371/journal.pone.0030604.g003
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treatment (Fig. 3b).
DRE activates the extrinsic pathway of apoptosis in
CMML cells
The first step in determining the mechanism of DRE-induced
apoptosis in human CMML was to assess the chronological
activation of caspases in DRE-treated cells. This should give some
insight to the pathway by which apoptosis is induced in these cells.
In order to observe the activation of caspases, MV-4-11 cells were
treated with DRE for various time points, following which, caspase
activity was assayed, using substrates specific to caspases-3, -8 and
-9. Results indicate that DRE rapidly activates caspase-8, followed
by subsequent activation of caspase-3 at later time points (Fig. 4a
and b) similar results were observed in HL-60 cells (data not shown).
In order to determine if caspase activation is required for the
induction of DRE-induced cell death in CMML cells, a pan-caspase
inhibitor,ZVAD-fmk,wasusedtopre-treatthe cellsforanhourand
then the cells were treated with DRE for different time points and
assayed for caspase-8 activation. Fig. 4c confirms the inhibition of
caspase-8 activation by ZVAD-fmk and this inhibition correlates
with the inability of DRE to induce apoptosis in MV-4-11 cells
following pre-treatment with the pan-caspase inhibitor (Fig. 4d).
These results indicate that caspases are required for the apoptosis-
inducing effects of DRE, more importantly, caspase-8 and -3.
From these results, we hypothesize that DRE activates the
extrinsic pathway of apoptosis. To confirm this effect on the
activation of the extrinsic pathway of apoptosis, we wanted to
observe the effect of DRE on cells with a dominant-negative
mutation in the Fas-Associated Death Domain (FADD) protein.
DnFADD cells were treated with DRE for 96 hours at increasing
concentrations and analyzed for the induction of apoptosis by
nuclear condensation and change in morphology. Results show that
DRE did not induce apoptosis in cells with a mutant FADD
domain, nor did it lead to a change in the morphology of these cells
(Fig. 5a). A trypan blue exclusion assay was used to evaluate the
effect of DRE on the number of cells after exposure to this extract,
compared to cells not treated with DRE. In fig. 5b, we observe no
significant difference between the control untreated cells and the
DRE-treated cells. Furthermore, activation of caspase-8 and 3 were
Figure 4. DRE activates the death-receptor-mediated extrinsic pathway of apoptosis. Following treatment with DRE, at indicated time
points and concentrations, MV-4-11 cells were collected, washed and incubated with lysis buffer to obtain cell lysate. The cell lysate was incubated
with caspase substrates, specific to each caspase (3,8 and 9) and incubated for an hour. Fluorescence readings were obtained using a
spectrofluorometer. An average of 6 readings per well and a minimum of three wells were run per experiment. The results here are reported as
activity per mg of protein (in fold) and the average of three experiments are shown (a,b). (c). Prior to DRE treatment, MV-4-11 cells were pre-treated
with a pan-caspase inhibitor, Z-VAD-fmk for an hour and then treated with DRE at the indicated concentration for indicated time points. These cells
were then incubated with caspase-8 substrate and fluorescence readings were obtained. These cells were also analyzed for the induction of
apoptosis by Hoechst and annexin-V staining (d). Magnification: 4006.
doi:10.1371/journal.pone.0030604.g004
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indicate that DRErequirestheFas-Associated DeathDomainforits
activation of the extrinsic pathway of apoptosis.
DRE destabilizes the mitochondrial membrane of CMML
cells
Due to the fact that the two different pathways of apoptosis can
target the mitochondria, the next step was to observe the effect of
DRE on the mitochondria of CMML cells affected by DRE. MV-
4-11 cells were treated with DRE for 24 hours and analyzed for
the destabilization of the mitochondrial membrane potential, using
a cationic lipophilic dye, JC-1, which aggregates in healthy
mitochondria with intact potential, to give off red fluorescence. A
loss or decrease in red fluorescence is therefore indicative of a loss
of mitochondrial membrane potential (MMP). Fig. 6a shows the
effect of DRE on the mitochondrial membrane of MV-4-11 cells.
Here, we observed a loss of red fluorescence, indicative of a loss of
intact mitochondrial membrane potential, indicating that DRE
has an indirect effect on the mitochondria of CMML cells, by
causing the dissipation of MMP. To further implicate the extrinsic
pathway of apoptosis in DRE-induced apoptosis, we wanted to
observe the effect on the mitochondria of DnFADD cells treated
with DRE. Fig. 6b shows the effect of DRE on the mitochondria of
DnFADD cells. Here, we observed a consistency in the red
fluorescence, indicating that the mitochondria of DnFADD cells
remained intact and were unaffected by treatment with DRE.
These results confirm that DRE does require FADD for its
induction of apoptosis.
Mitochondria are considered the major players in the
production of reactive oxygen species (ROS) under physiological
conditions. The levels of the ROS increase drastically under
pathological conditions, thereby leading to the induction of cell
death [12]. Furthermore, the production of ROS is known to have
dual roles; it could be the cause or effect of the induction of
apoptosis. ROS has been shown to induce the activation of certain
death receptors, such as Fas and TNF [13]. Therefore, these
points of evidence implicate the mitochondria in the initiation
and/or execution of apoptosis. Therefore, to further assess the
effect of DRE on the mitochondria of CMML cells, the production
of ROS was studied. To do this, the mitochondria were isolated
from MV-4-11 and HL-60 cells and were treated directly with
DRE. ROS production was assessed by incubation with Amplex
Red dye over 4 hours, with readings taken at 5-minute intervals.
Paraquat (PQ), is a known inducer of ROS production in the
mitochondria [14] and this was used as a positive control of ROS
production in both MV-4-11 and HL-60 cells. In both cell lines, it
can be observed that there is an increase in the production of ROS
in DRE-treated cells compared to the control untreated cells; in
the MV-4-11 cells, this increase surpasses that of the PQ treated
cells (Fig. 7a and b). Therefore, these results are indicative of the
mitochondria as an indirect target of DRE.
DRE induces pro-death autophagy in MV-4-11 cells
Autophagy, also known as ‘‘self-eating’’, is an evolutionary
conserved process that is known to play a significant role in the
maintenance of cellular homeostasis. It is the primary degradation
Figure 5. DRE required the Fas-Associated Death Domain (FADD) for its activity. (a). Dominant-negative FADD (DnFADD) cells were
treated with DRE at indicated concentrations, for 96 hours and analyzed for the induction of apoptosis by nuclear condensation (Hoechst) and
change in morphology (Phase contrast). Magnification: 4006. (b). Following treatment with DRE, DnFADD cells were collected and cell number was
obtained using the trypan blue exclusion assay. Live cells were impermeable to the trypan blue dye. (c). DnFADD cells were treated with DRE for the
indicated time points and analyzed for the activation of caspase-8, using caspase-8 specific substrate and fluorescence readings were obtained. An
average of 6 readings per well and a minimum of three wells were run per experiment. The results here are reported as activity per mg of protein (in
fold) and the average of three experiments are shown.
doi:10.1371/journal.pone.0030604.g005
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proteins, as well as, defective organelles [15]. It is reported to play
a dual role, as it supports cell survival and cell death (in extreme
cases of ‘‘self-eating’’) [16]. Various cellular stressors, such as
hypoxia, starvation, protein aggregation and ROS production,
usually induce this process. The presence of these stressors leads to
the formation of the autophagosome, a double membrane vesicle,
around the protein or organelle to be degraded. The autophago-
some will fuse to the lysosome and its contents can be degraded
[17,18]. In order to assess the induction of autophagy in CMML
cells, MV-4-11 cells were treated with DRE for 48 hours, then
stained with monodansylcadaverine (MDC) dye and counter-
stained with propidium iodide to observe cell death. Tamoxifen
(TAM), a known inducer of pro-survival autophagy [19], was used
as a positive control. Results indicate that, unlike TAM, DRE does
induce a pro-death form of autophagy, as characterized by the
bright punctate MDC staining, as well as the propidium iodide
positive staining, in DRE-treated cells, comparable to the TAM-
treated cells. These cells were more brightly stained than the
control untreated cells (Fig. 8; top panel).
DRE is selective to CMML cells, with little toxicity on
normal, non-cancerous cells
Dandelions have been used for centuries for nourishment and
therapy, with few reports of little to no toxicity, due to the lack of
toxins and alkaloids present in this plant. High doses have been
reported to cause allergic contact dermatitis, although this was
shown in studies using dandelion extract as a topical treatment [6].
In order to assess toxicity of DRE in the lab, non-cancerous
peripheral blood mononuclear cells (ncPBMCs) were isolated from
the blood of apparently healthy volunteers, according to a
previously published protocol [20]. These cells were plated into
six-well culture plates and treated with DRE at increasing
concentrations for 96 hours, then analyzed for the induction of
apoptosis. Results show that DRE does not induce apoptosis in
ncPBMCs, even at high doses (Fig. 9a and b). As ncPBMCs are
not actively proliferating in culture, some isolated PBMCs were
pre-incubated with concanavalin A (conA), a plant mitogen known
to stimulate T cell proliferation in vitro [21]. These cells were then
exposed to DRE treatment and analyzed for the induction of
apoptosis. As with the ncPBMCs not pre-treated with conA, those
pre-incubated with conA and subsequently treated with DRE
remained unsusceptible to DRE-induced apoptosis (data not
shown). These results have also been shown in other non-
cancerous cell lines, for example, normal human fibroblasts
(NHFs) [8]. To further evaluate the selective induction of cell
death in ncPBMCs, these cells were treated with DRE for
48 hours and stained with MDC and PI to assess the induction of
pro-death autophagy, using tamoxifen as a positive inducer of
autophagy. Figure 8 (bottom panel) indicates that tamoxifen
effectively induced autophagy in ncPBMCs, ultimately leading to
the cell death, observed with propidium iodide staining.
Importantly, there was no induction of autophagy in these cells,
as compared to the control, untreated cells. These DRE treated
cells were also impermeable to propidium iodide, confirming the
lack of cell death in ncPBMCs treated with DRE. These results
Figure 6. DRE destabilizes the mitochondria membrane
potential of MV-4-11 cells. (a). Following treatment with DRE, MV-
4-11 cells were incubated with JC-1 dye to detect the loss of
mitochondrial potential (ref to Materials and Methods). Red fluores-
cence indicates only cells that have healthy mitochondria. The
mitochondria of MV-4-11 cells are completely destabilized by DRE
treatment. On the other hand, the mitochondria of DnFADD cells
remained unaffected by DRE treatment (b). Magnification: 4006.
doi:10.1371/journal.pone.0030604.g006
Figure 7. DRE increases ROS production in isolated mitochon-
dria from CMML cells. Isolated mitochondria from (a) MV-4-11 and
(b) HL-60 cells were treated directly with 1.0 mg/ml DRE and ROS
production was measured using Amplex Red substrate in the presence
of horseradish peroxidase (HRP). Results were compared to control
untreated mitochondria and positive control, paraquat (PQ). Fluores-
cence readings were taken in 5 min intervals for 4 h at Ex. 560 nm and
Em.590 nm and expressed as relative fluorescence units (RFU). Analysis
of results were performed using GraphPad Prism version 5.0 and results
shown are representative of 3 independent experiments demonstrating
similar trends.
doi:10.1371/journal.pone.0030604.g007
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making it selective to CMML cells.
Discussion
The poor prognosis for Chronic Myelomonocytic Leukemia
(CMML) patients is a major indication that there is a serious need
for a more effective and non-toxic alternative to the conventionally
available forms of chemotherapy and surgical procedures [4].
With the introduction of natural products, not only as sources of
nourishment, but also for their therapeutic benefits, it is therefore
necessary to study the vast array of natural products as non-toxic
and less expensive alternatives for the treatment of CMML.
Apoptosis and autophagy, two necessary modes of programmed
cell death, are important mechanisms, which cells utilize for the
maintenance of cellular homeostasis [22]. Cancer cells, however,
have developed mechanisms to evade these programs, so as to
enable enhanced proliferation, aggressiveness and resistance
[23,24]. In this study, we demonstrate the selective efficacy of
dandelion root extract in inducing apoptosis and autophagy in
highly aggressive and resistant CMML cell lines.
We observed the induction of apoptosis in three of the CMML
cell lines used for this study (Fig. 1). More importantly, this effect
was selective, as non-cancerous PBMCs and NHFs remained
unsusceptible to DRE-induced apoptosis (Fig. 9a and b).
Although various extracts of dandelions have been used for
centuries for the treatment of various diseases, there have been
very few scientific studies done to ascertain the mechanism by
which these extracts act and although some of the compounds
present in dandelion extracts have been isolated and identified,
they still are not fully characterized [6,7]. The major aim of the
study was therefore to determine the mechanism of DRE-induced
cell death in CMML cells.
Figure 8. DRE triggers pro-death autophagy in MV-4-11 cells but not in non-cancerous Peripheral blood mononuclear cells
(ncPBMCs). MV-4-11 cells were treated with DRE for 48 hours and analyzed for the induction of autophagy; Tamoxifen (TAM) was used as a positive
control for the induction of pro-surivival autophagy. Following treatment, the cells were stained with MDC to detect autophagic vacuoles and
counterstained with PI to detect cell death. Fluorescence images were captured. Magnification: 4006.
doi:10.1371/journal.pone.0030604.g008
Figure 9. DRE does not target normal non-cancerous periph-
eral blood mononuclear cells (ncPBMCs). (a). ncPBMCs were
isolated from healthy volunteers and plated in six-well plates. These
cells were treated with DRE at increasing concentrations for 96 hours
and analyzed for the induction of apoptosis by nuclear condensation
(Hoechst) and externalization of the phosphatidylserine (Annexin-V
binding). Magnification: 4006.( b ) .R e s u l t sf r o mt h r e ed i f f e r e n t
experiments were quantified to determine the percentage of apoptosis
occurring in ncPBMCs treated with DRE.
doi:10.1371/journal.pone.0030604.g009
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minutes) and subsequent activation of caspase-3 in human CMML
cells, indicative of a speedy activation of the death receptor
mediated extrinsic pathway of apoptosis (Fig. 4a and b). This
activation has been shown to be necessary for the induction of
apoptosis observed after DRE treatment, as the inhibition of
caspase activity, using a pan-caspase inhibitor, ZVAD, prevented
the induced cell death observed (Fig. 4c and d). These results
suggest that caspases, more importantly, caspase-8 and 3, are
required for the induction of apoptosis by DRE. The Fas-
Associated Death Domain (FADD), as well as other death
domains, are highly important for activation of caspase-8 through
extrinsic apoptosis [25]. The binding of the death ligand to its
corresponding death receptor leads to the recruitment of specific
receptor death domains for the formation of the death inducing
signalling complex (DISC) [26]. The absence of FADD should
therefore prevent the activation of the extrinsic pathway of
apoptosis through inhibition of the activation of caspase-8 [27]. To
further confirm the effect of DRE on the extrinsic pathway of
apoptosis, DnFADD cells were treated with DRE and analyzed for
apoptosis induction. According to our results, no nuclear
condensation and morphological changes were observed with
the treatment of DRE. There was no change in the number of cells
treated with DRE, compared to the control untreated cells,
suggesting that DRE did not have a significant effect on the cells
with a truncated FADD protein (Fig. 5a and b). Furthermore,
these cells were not susceptible to DRE-induced rapid activation of
caspases, specifically caspase-8 (Fig. 5c). As we observed late
activation of caspase-3, we wanted to observe the connection
between the intrinsic and the extrinsic pathway of apoptosis. It is
known that the activation of caspase-8 could yield two main
results. First, the activated caspase-8 could lead directly to the
activation of the effector caspase, caspase-3 or it could lead to
mitochondrial changes, through the cleavage of pro-apoptotic
protein, Bid. The truncation of Bid causes mitochondrial
membrane destabilization, which leads to the release of pro-
apoptotic proteins for the activation of caspase-3 [26]. In this
study, we observed the destabilization of the mitochondrial
membrane potential 24 hours after treatment with DRE. This
destabilization of mitochondrial membrane potential was only
observed in MV-4-11 cells, not in DnFADD cells (Fig. 6a and b).
These results suggest that DRE indirectly targets the mitochondria
after the activation of the extrinsic pathway of apoptosis. It
confirms the requirement of the adapter domain for DRE-induced
apoptosis, as we do not observe a similar loss of mitochondrial
membrane potential in DnFADD cells treated with DRE. As the
mitochondria are major players in the production of ROS [28],
the next step was to observe the effect of DRE on the production
of ROS. Results confirm the production of ROS from isolated
mitochondria (Fig. 7a and b), further confirming the effect of DRE
on the mitochondria of CMML cells.
The integrity of the mitochondria is essential for the
maintenance of cellular homeostasis and defects in the mitochon-
dria caused by treatment with DRE could provide sufficient signals
for the induction of programmed cell death type II, also known as
Autophagy, a process induced by the presence of defective
organelles, proteins and starvation [29]. Autophagy has been
shown to play a significant role in cancer survival and its role in
programmed cell death has been controversial. In response to
stressors, cells undergo ‘‘self-digestion’’ as a means of temporary
survival, where macromolecules are digested in order to provide
an alternate energy source. However, excessive exposure to
stressors could lead to excessive autophagy, ultimately resulting
in cell death [18,30]. The loss of mitochondrial membrane
potential, observed after treatment with DRE, therefore led us to
determine if the stress induced by our extract, leading to
mitochondrial membrane destabilization was a sufficient signal
for the induction of autophagy. Our results indicate that treatment
with DRE triggered the induction of a pro-death form of
autophagy in MV-4-11 cells (Fig. 8; top panel). Comparing this
to treatment with tamoxifen, which is known to induce pro-
survival in cancer cells, treatment with DRE not only triggered
autophagy, comparable to TAM, the cells were also propidium
iodide positive, indicative of cell death. Moreover, ncPBMCs
stained with MDC and PI showed no induction of autophagy in
these cells after DRE treatment (Fig. 8; bottom panel). These
results suggest that DRE is effective in selectively inducing both
forms of programmed cell death in human CMML cells.
In conclusion, Dandelion Root Extract has shown selective
efficacy in inducing two forms of programmed cell death in highly
aggressive and resistant CMML cell lines. The rapid activation of
caspase-8 not only activated the extrinsic pathway of apoptosis,
but also triggered pro-death autophagy selectively in these cells,
suggesting that this extract has components that enhance its
selective efficacy in targeting CMML cells. These results indicate
that within the vast array of available natural products and
compounds, there are non-toxic alternatives to conventional
chemotherapy that are safe and effective.
Materials and Methods
Standardized Dandelion Root Extraction
Freshly obtained Dandelion roots (from open grassy areas) were
processed according to a previously published protocol [9]. The
roots were thoroughly washed with distilled water several times.
One hundred grams of Dandelion roots were homogenized in
200 ml of distilled water at room temperature using a domestic
blender. Total homogenate was filtered through a NITEX nylon
mesh filter (LAB PAK; Sefar BDH Inc. Chicoutimi, Quebec CA)
and the filtrate was spun down, 80006g for 5 min at 25uC. The
supernatant was filtered using 0.45 mm filters, followed by
lyophilisation. The dry powder (% yield: 7.34%) was reconstituted
in water to give a stock solution of 100 mg/ml DRE. This was
then filtered through 0.22 mm filters and used in the treatment of
Chronic Myelomonocytic leukemia cells.
Cell Culture and Treatment
Human CMML cell lines (MV-4-11, HL-60 and U-937 cells), as
well as a dominant negative FADD Jurkat cell line was purchased
from ATCC (Manassas, VA.). MV-4-11 and HL-60 cells were
cultured in Iscove’s Modified Dulbecco’s Medium, supplemented
with 15% fetal bovine serum (FBS) and 40 mg/ml gentamicin (Life
Technologies, Mississauga, Ontario). The DnFADD cells were
cultured in RPMI-1640 medium supplemented with 15% FBS and
40 mg/ml gentamicin. These cells were grown and maintained in
an incubator set at 37uC with an atmosphere containing 5% CO2
and 95% humidity. Human nucleated blood cells were purified
from whole blood obtained from healthy volunteers, modified
from a previously published protocol [31] and as approved by the
University of Windsor ethical committee, REB# 04-060. Whole
blood (12 ml) was collected into a BD Vacutainer CPT Tube (Cell
Preparation Tube) obtained from Becton Dickinson (Franklin
Lakes, N.J.). The whole blood was spun down in a tabletop low-
speed centrifuge at 29006 g for 30 min at 25uC. The red blood
cells went through the polyester gel and the top layer containing
mononuclear cells, platelets and plasma was collected. These cells
were kept in the same incubator as the CMML cells (37uC, 5%
CO2 and 95% humidity) and cultured in AIM-V medium from
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autophagy by treatment with Dandelion Root Extract (DRE),
Cells were grown to 50–70% confluence and then treated either
with different concentrations of lyophilized extract (0.6 mg/ml to
5.0 mg/ml). At different times after treatment, cells were analyzed
for apoptotic markers as described below.
Cell staining
Trypan Blue Exclusion Assay. To examine the ability of
MV-4-11 cells to revive growth after previous exposure to DRE,
these cells were treated with DRE for 48 hours, after which the
cells were removed from media containing extract and equal
number of cells were replated and examined every day. After
treatment, a cell suspension was added (1:1) to Trypan Blue stain
(Life Technologies). Using a hemacytometer (Fisher Scientific,
Horsham, Pa.), live cells (trypan blue negative) were counted three
times, calculated and tabulated as number of cells per ml using
GraphPad Prism 5.0 288 software.
Hoechst Staining. Cells were grown and treated, and then
stained with cell-permeable Hoechst 33342 (Molecular Probes,
Eugene, Ore.), at a final concentration of 10 mM and incubated
for 10 min at 37uC. The cells were then examined under a
fluorescent microscope (Leica DM IRB, Germany) and fluorescent
pictures were taken. Five fields of fluorescent pictures were used to
count apoptotic versus live cells (where brightly stained cells with
condensed nuclei were considered apoptotic). These results were
then calculated and tabulated as percentage of apoptotic cells
using GraphPad Prism 5.0 288 software.
Annexin-V Binding Assay. To confirm the induction of
apoptosis by staining for phosphotidylserine exposed on the outer
leaflet of the plasma membrane (a characteristic feature of
apoptosis), CMML cells were grown and treated with different
concentrations of DRE. The cells were collected after given
periods as indicated, washed in phosphate-buffered saline (PBS)
and resuspended in annexin-V binding buffer (10 mM HEPES/
NaOH pH 7.5, 140 mM NaCl, 2.5 mM CaCl2), containing 1:50
annexin-V Alexa Fluor 488 conjugate (catalog no. A13201,
Molecular Probes) for 15 min at room temperature. Cells were
then examined under a fluorescent microscope (Leica DM IRB),
and pictures were taken. All pictures were processed using Adobe
Photoshop 7.0 software.
Mitochondrial Membrane potential. JC-1 Mitochondrial
Membrane Potential Detection Kit was applied to monitor mito-
chondrial membrane destabilization in cells undergoing apoptosis. In
non-apoptotic cells with healthy mitochondria, JC-1 (5, 59,6 ,6 9-
tetrachloro-1, 19,3 ,3 9 tetraethylbenzimidazolylcarbocyanine iodide)
(Catalog. No. M34152, Burlington, ON) exists as a monomer in the
cytosol and also accumulates as aggregates in the mitochondria which
fluoresce red. In apoptoticand necroticcells, JC-1 exists in monomeric
form, diffused in the cytosol where it fluoresces green. MV-4-11 and
DnFADD cells were collected after treatment and incubated with
100 mL per ml JC-1 dye for 15 min at 37uC. The cells were examined
under fluorescent microscope (Leica DM IRB) and fluorescent
pictures were taken. All pictures were processed using Adobe
Photoshop 7.0 software.
Monodansylcadaverine (MDC) Staining. Monodansylca-
daverine (MDC) (Sigma-Aldrich Canada, Mississauga, ON,
Canada) was used to visualize autophagic vacuoles. CMML cells
were plated in six-well plates and treated with different con-
centrations of DRE for 48 hours. After treatment, cells were
incubated with 0.1 mM MDC for 30 minutes. Fluorescent
pictures were acquired at 4006 magnification on a Leica DM
IRB inverted fluorescence microscope.
Propidium Iodide Staining. Cell death was detected by cell
lysis observed by staining with propidium iodide (PI) dye (Sigma
Aldrich, Canada, Missisauga, ON. Canada). After incubating with
MDC dye for 15 minutes, cells also co-stained with PI at a
concentration of 1.0 mg/mL for the last 15 minutes of incubation
with MDC. Following incubation, the cells were visualized and
images were taken using a fluorescence microscope at 4006
objective.
TUNEL staining. After treating MV-4-11 cells with DRE for
the indicated time points, the TUNEL assay was performed
according to the manufacturer’s protocol (Molecular Probes,
Eugene, OR) and a previously published protocol [32], in order to
detect DNA damage. Cells were treated with DRE or VP-16 (as a
positive control) at indicated concentrations and time points and
analyzed for the fragmentation of DNA. Following treatment, cells
were fixed by suspending them in 70% (v/v) ethanol and stored at
220uC overnight. The sample was then incubated with a DNA
labeling solution (10 mL reaction buffer, 0.75 mL TdT enzyme,
8 mL BrdUTP, 31.25 mL of dH2O) for 1 hour at 25uC. Each
sample was exposed to an antibody solution (5 mL Alexa Fluor 488
labeled anti-BrdU antibody and 95 mL rinse solution). The cells
were incubated with the antibody solution for 20 minutes and
pictures were taken using a fluorescent microscope (Leica DM
IRB, Germany).
Cell viability Assay
To examine the viability of MV-4-11 cells after treatment, cells
were incubated with cell proliferation reagent WST-1 (Catalog
No. 05 015 944 001, Roche Diagnostics) for 4 h at 37uC,
following treatment with DRE at indicated doses and time points,
using manufacturers protocol. WST-1 works by reacting with the
mitochondrial succinate-tetrazolium reductase forming the form-
azan dye. The WST-1 reagent produces a water-soluble formazan
product [33]. Fluorescence readings were obtained at 450 nm
using a Perkin Elmer Victor Fluorescence machine. Viability
readings were analyzed using GraphPad Prism 5.0 288 software
and expressed as percentages of the control untreated groups.
Caspase Activity
The Caspase assays were performed using a previously published
method [34]. To determine caspase activity, the total protein from
MV-4-11, HL-60 and DnFADD cell lysates were incubated with the
fluorogenic substrates corresponding to the substrate cleavage site,
specific for each caspase, DEVD-AFC for Caspase-3 and IETD-
AFC for Caspase-8. The fluorescence was measured at an excitation
wavelength of 400 nm and emission wavelength of 505 nm using a
Spectra Max Gemini XS (Molecular Devices, Sunnyvale, Califor-
nia). Caspase activity was calculated as activity per mg protein and
protein concentration was determined with BioRad protein assay
reagent (BioRad, Mississauga, Ontario) using bovine serum albumin
(BSA) as a standard. Readings were analyzed using GraphPad Prism
5.0 288 software. To furtherconfirmthe roleofcaspases inapoptosis
induction by DRE, the zVAD-fmk caspase inhibitor (Catalog
No. 219007, EMD4Biosciences, San Diego, California), was
incubated with MV-4-11 cells an hour before treatment described
above. Some cells were collected, washed in PBS and stained with
Hoechst 33342. Others were analyzed for the activation of caspases,
using fluorogenic substrates described above, after DRE treatment.
Mitochondrial Isolation and measurement of ROS
production
Mitochondria were isolated from untreated MV-4-11 and HL-
60 cells for analysis of ROS production. Cells were washed twice
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5 mM Tris–HCl, 210 mM mannitol, 70 mM sucrose, 10 mM
Leu-pep, 10 mM Pep-A, and 100 mM PMSF) and immediately
homogenized, and centrifuged at 6006 g for 5 minutes at 4uC.
The supernatant was centrifuged at 15,0006g for 15 minutes at
4uC. The resulting cytosolic supernatant was discarded and the
mitochondrial pellet was resuspended in cold hypotonic buffer.
To measure the production of ROS, Amplex Red (Molecular
Probes, Eugene, OR) was used. The isolated mitochondria were
resuspended in cold hypotonic buffer and 20 mg of protein was
added to wells of a 96-well opaque plate. Treatment was done with
1.0 mg/ml DRE and as a positive control, 250 mM paraquat (PQ)
(Sigma Aldrich, Missisauga, ON. Canada) was used for treatment.
Amplex Red reagent was added to each well for a final
concentration of 50 mM; horseradish peroxidase (HRP) was added
in the ratio of 6units per 200 mL. Fluorescence readings were
taken every 5 minutes for a total time of 4 hours at Ex. 560 nm
and Em. 590 nm on a spectrofluorometer (SpectraMax Gemini
XS, Molecular Devices, Sunnyvale, CA). The readings were
analyzed using GraphPad Prism 5.0 288 software and expressed as
relative fluorescence units (RFU).
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